By staff writers

December 21, 2016 -- Medical statistics and data mining firm Statlife has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its DenSeeMammo breast density assessment software.

The software provides a standardized and automatic breast density evaluation according to BI-RADS guidelines and can be combined with Statlife's MammoRisk risk assessment tool, the company said. It is compatible with GE Healthcare's Senographe Essential mammography systems, according to Statlife.

Copyright © 2016

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking